𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Schedule-dependent Efficacy of Camptothecins in Models of Human Cancer

✍ Scribed by PETER J. HOUGHTON; CLINTON F. STEWART; WILLIAM C. ZAMBONI; JOYCE THOMPSON; XIALOLONG LUO; MARY K. DANKS; JANET A. HOUGHTON

Book ID
119872950
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
723 KB
Volume
803
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel camptothecin derivative BNP1350 in
Novel camptothecin derivative BNP1350 in experimental human ovarian cancer: Determination of efficacy and possible mechanisms of resistance
✍ Annemarie H. van Hattum; Hennie M.M. SchlΓΌper; Frederick H. Hausheer; Herbert M. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 236 KB πŸ‘ 1 views

## Abstract The novel camptothecin derivative BNP1350 (7‐[2‐trimethylsilyl)ethyl]‐20(__S__)‐camptothecin), also known as Karenitecin, has been developed for superior oral bioavailability and increased lactone stability. In our study, we describe the antiproliferative effects of BNP1350, SN‐38 and t

Schedule-dependent interaction of doxoru
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
✍ Wainer Zoli; Luca Ricotti; Fabio Barzanti; Monica Dal Susino; Giovanni Luca Fras πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 106 KB πŸ‘ 2 views

We showed previously that a sequential treatment with doxorubicin (4 hr) followed by paclitaxel (24 hr) (Dox=Pacl) induces a synergistic cytotoxic effect in the BRC-230 breast cancer cell line and in human primary breast cancer cultures. The validity of this experimental finding was confirmed in a c